Zhirui Wang
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$2.9MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 17, 2026 | NIH | STTR Phase I Bivalent CD47 Immunotoxin for Targeted Therapy of T-Cell Acute Lymphoblastic Leukemia | $400K | ROCK IMMUNE LLC |
| Mar 4, 2025 | NIH | STTR Phase II CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma | $248K | ROCK IMMUNE LLC |
| Mar 6, 2024 | NIH | STTR Phase II CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma | $876K | ROCK IMMUNE LLC |
| Feb 1, 2023 | NIH | STTR Phase II CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma | $1.0M | ROCK IMMUNE LLC with UNIVERSITY OF COLORADO DENVER |
| Jul 27, 2021 | NIH | STTR Phase II CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma | $400K | ROCK IMMUNE LLC |
Peer ranks
Federal funding#642
Awards as PI#417
Patents#273
Companies
- ROCK IMMUNE LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.